Microfluidic analysis of ligand induced cell expression
AssigneeEuropean Molecular Biology Laboratory
InventorsHongxing Hu, Samantha Seah, Christoph A. Merten
Life of this patent
Estimating the term…
Abstract
The present invention relates to the field of microfluidics and in particular to analysing the gene expression of a cell in response to a ligand expressed in the same microfluidic compartment. By barcoding the transcriptome of the cell and of the expression system generating the ligand, the effect of the ligand on the cell expression can be discerned. The invention provides microfluidic compartments and methods for this purpose.
Claims26
A plurality of microfluidic compartments, wherein at least 1% of said compartments form a subset in which each compartment is a droplet comprising:
- (i) a first cell,
- (ii) one second cell, the second cell expressing a polypeptide ligand intended to specifically bind to a molecule or part thereof accessible on a surface of the first cell, wherein the one second cell is a cell of B-cell lineage and
- (iii) a set of barcode oligonucleotides each comprising a barcode sequence unique to the set and a sequence capable of binding specifically to mRNA and/or cDNA of the first cell and mRNA and/or cDNA of the one second cell.
A method for determining the gene expression of a cell, comprising the steps:
- (a) providing a plurality of microfluidic compartments wherein at least 1% of said compartments form a subset in which each compartment is a droplet comprising:
- (i) a first cell,
- (ii) one second cell or one cell-free expression system, the second cell or the cell-free expression system expressing a polypeptide ligand intended to specifically bind to a molecule or part thereof accessible on a surface of the first cell, and
- (iii) a set of barcode oligonucleotides each comprising a barcode sequence unique to the set and a sequence capable of binding specifically to mRNA and/or cDNA of the first cell and mRNA and/or cDNA of the one second cell or the one cell-free expression system,
- (b) lysing the cells comprised in the compartments,
- (c) reverse transcribing mRNA released from the cells to cDNA,
- (d) amplifying the cDNA,
- (e) determining the sequence and optionally the respective amount of the cDNA, and
- (f) selecting sequences comprising the same barcode sequence, wherein the following sequences are excluded:
- sequences derived from a second cell or a cell-free expression system,
- sequences comprising a unique barcode sequence that is not associated in other sequences with a nucleotide sequence encoding for a polypeptide ligand expressed by a second cell or a cell-free expression system,
- sequences comprising a unique barcode sequence that is associated with a nucleotide sequence encoding for more than one polypeptide ligand expressed by a second cell or a cell-free expression system,
- wherein step (c) or step (d) is carried out with a barcode oligonucleotide as a primer.
A plurality of microfluidic compartments, wherein at least 1% of said compartments form a subset in which each compartment is a droplet comprising:
- (i) a first cell,
- (ii) one second cell or one cell-free expression system, the second cell or the cell-free expression system expressing a polypeptide ligand intended to specifically bind to a molecule or part thereof accessible on a surface of the first cell, and
- (iii) a set of barcode oligonucleotides each comprising a barcode sequence unique to the set and a sequence capable of binding specifically to mRNA and/or cDNA of the first cell and/or of the one second cell or the one cell-free expression system,
- wherein the compartment volume of the subset and the cell concentration of the first cell (i), the cell concentration or cell-free expression system concentration of the one second cell or the one cell-free expression system (ii), and the set concentration of the set of barcode oligonucleotides (iii) is such that λ is between 0.1 and 2 for each of the cell concentration of the first cell (i), the cell concentration of the one second cell or cell-free expression system concentration of the one cell-free expression system (ii), and the set concentration of the set of barcode oligonucleotides (iii),
- wherein λ is the average number of cells, cell-free expressions systems and sets of the barcode oligonucleotides per compartment volume of the subset.
Dependencies are inferred from the claim text.